Evidence map›Paper›PMID 22567286›Full record

ArticleBiochemistry research international2012

Sumoylation of human translationally controlled tumor protein is important for its nuclear transport.

Gnanasekar Munirathinam, Kalyanasundaram Ramaswamy

Open access · goldAbstract read
In one paragraph

Article in Biochemistry research international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Gnanasekar MunirathinamDepartment of Biomedical Sciences, College of Medicine, University of Illinois, Rockford, IL 61107, USA.
Kalyanasundaram Ramaswamy
University of Illinois Chicago, Rockford campus · US

Funding

MULTIVALENT VACCINE FOR LYMPHATIC FILARIASISR01AI064745 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KALYANASUNDARAM, RAMASWAMY · 2007 to 2010
$1.5M
HOST IMMUNOMODULATION BY PARASITESR01AI039066 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KALYANASUNDARAM, RAMASWAMY · 2002 to 2004
$696k
MULTIVALENT VACCINE FOR LYMPHATIC FILARIASISR56AI064745 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KALYANASUNDARAM, RAMASWAMY · 2006 to 2006
$310k
CUTANEOUS IMMUNE RESPONSE TO PARASITIC INFECTIONR29AI039066 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KALYANASUNDARAM, RAMASWAMY · 1996 to 2000
$109k
NIAID NIH HHS R01 AI039066NIAID NIH HHS R01 AI064745NIAID NIH HHS R29 AI039066NIAID NIH HHS R56 AI064745
6 · The paper itself

Abstract

Translationally controlled tumor protein (TCTP) lacks nuclear bipartite localization signal sequence; yet TCTP is present abundantly in the nucleus. At present it is not known how TCTP gets transported to the nucleus. Sequence analyses showed that all TCTPs described to date have putative small ubiquitin-like modifier (SUMO) motifs. Since SUMO modification plays an important role in the nuclear transport of proteins, we evaluated whether SUMO motifs are important for transport of TCTP into the nucleus. We show that TCTP exists in sumoylated form in cytoplasm and nucleus of mammalian cells. Point mutation of lysine residue in the SUMO motif compromised the ability of TCTP to get sumoylated in vitro. When cells were transfected with FLAG-tagged mutated TCTP, nuclear transport of TCTP was inhibited confirming that sumoylation is critical for the nuclear transport of TCTP. Our previous studies demonstrated that TCTP can function as an antioxidant protein in the nucleus. When we mutated TCTP at the SUMO motif the antioxidant function of TCTP was compromised. Results presented in this study thus show that sumoylation plays an important role in the transport of TCTP into the nucleus where they function as antioxidant protein.

Identifiers

PMID22567286
PMCPMC3332165
OpenAlexW1984064065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.